CN102940793A - Traditional Chinese medicine composition for treating purpura - Google Patents

Traditional Chinese medicine composition for treating purpura Download PDF

Info

Publication number
CN102940793A
CN102940793A CN2012103472880A CN201210347288A CN102940793A CN 102940793 A CN102940793 A CN 102940793A CN 2012103472880 A CN2012103472880 A CN 2012103472880A CN 201210347288 A CN201210347288 A CN 201210347288A CN 102940793 A CN102940793 A CN 102940793A
Authority
CN
China
Prior art keywords
parts
herba
chinese medicine
radix
purpura
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012103472880A
Other languages
Chinese (zh)
Other versions
CN102940793B (en
Inventor
柳晖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yu Qing
Original Assignee
Quantum Dental Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quantum Dental Technologies Inc filed Critical Quantum Dental Technologies Inc
Priority to CN201210347288.0A priority Critical patent/CN102940793B/en
Publication of CN102940793A publication Critical patent/CN102940793A/en
Application granted granted Critical
Publication of CN102940793B publication Critical patent/CN102940793B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating purpura. The medicine is composed of the following Chinese medicinal materials, by weight: 10-40 parts of dried rhizome of rehmannia, 10-40 parts of Herba Cirsii, 10-40 parts of hairyvein agrimony, 5-20 parts of gardenia, 10-40 parts of Eclipta alba, 10-40 parts of rhizoma nelumbinis, 10-30 parts of rhizoma anemarrhenae, 5-25 parts of Radix Scrophulariae, 5-20 parts of moutan bark, 10-30 parts of lithospermum erythrorhizon, 10-40 parts of dandelion, 5-20 parts of lophatherum gracile, 10-40 parts of Rhizoma imperatae, 5-25 parts of Ophiopogon, and 5-20 parts of golden cypress. The traditional Chinese medicine composition provided by the invention has efficacies of clearing heat, moisturizing dampness, discharging fire, detoxifying, cooling blood to stop bleeding, nourishing yin, promoting the secretion of saliva, promoting blood circulation and removing blood stasis, obvious curative effect on purpura and reliable effects; and the components have wide medicine source, simple preparation and no toxic or side effect.

Description

A kind of Chinese medicine composition for the treatment of purpura
Technical field
The present invention relates to a kind of medicinal preparation of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of purpura.
Background technology
Purpura is the general name of color change behind skin and the mucosal bleeding.Clinical manifestation is petechia, purpura and ecchymosis, does not generally exceed surface, only can slightly swell when anaphylactoid purpura, begins to be aubergine, presses not fade, and shoals gradually later on, disappears to two all left and right sides flavescence.Onset is more anxious, and purpura occurs repeatedly, can betide skin, the mucosa at each position of whole body.Erythra is various, little person such as needle point sample, and large person then becomes ecchymosis or hematoma, also can merge in flakes.During Acute onset, often with epistaxis, bleeding from the gum, have blood in stool, the symptom such as hematuria or vomiting, stomachache, arthralgia.Because primary disease is hematostaxis, without obvious inducement, and without obvious simultaneous phenomenon, so bring certain difficulty to treatment.At present, adopt Chinese patent medicine such as Cornu rhinocerotis Dihuang Wan, ZHONGJIEFENG PIAN, tablet of cow-bezoar for tranquilization, Folium Nelumbinis ball etc. to treat to purpura clinically, exist the poor deficiency of therapeutic effect.
The traditional Chinese medical science thinks that purpura has dividing of deficiency and excess take the disease appearing in blood system as main.Outer because the heresy of affection due to external wind and heat, the damp and hot poison of holding under the arm accumulates and hinders in flesh table blood system, the absurd row of forcing blood, excessive skin pores key is take excess syndrome as main.In because plain body-centered temper insufficiency of blood, due to the damage of kidney-YIN, hyperactivity of deficient fire, escape of blood from meridian, take deficiency syndrome as main.
According to theory of Chinese medical science, for the pathogeny of purpura, excess syndrome is take clearing away heat and cooling blood as the Therapeutic Principle, and deficiency syndrome are carried out dialectical composition of prescription take nourishing qi to stop, nourishing YIN to lower pathogenic fire as the Therapeutic Principle, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome the deficiencies in the prior art, the invention provides a kind ofly prepare conveniently, the medicine source is wide, cost is low, the Chinese medicine composition of evident in efficacy, reliable effect, the treatment purpura that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of purpura is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 10~40 parts in the Radix Rehmanniae, 10~40 parts of Herba Cirsiis, 10~40 parts of Herba Agrimoniaes, 5~20 parts of Fructus Gardeniae, 10~40 parts of Herba Ecliptaes, 10~40 parts of Nodus Nelumbinis Rhizomatis, 10~30 parts of the Rhizoma Anemarrhenaes, 5~25 parts of Radix Scrophulariaes, 5~20 parts of Cortex Moutans, 10~30 parts of Radix Arnebiae (Radix Lithospermi)s, 10~40 parts of Herba Taraxacis, 5~20 parts of Herba Lophatheris, 10~40 parts of Rhizoma Imperataes, 5~25 parts of Radix Ophiopogonis, 5~20 parts of Cortex Phellodendris.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of purpura is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 30 parts in the Radix Rehmanniae, 30 parts of Herba Cirsiis, 30 parts of Herba Agrimoniaes, 12 parts of Fructus Gardeniae, 30 parts of Herba Ecliptaes, 30 parts of Nodus Nelumbinis Rhizomatis, 20 parts of the Rhizoma Anemarrhenaes, 15 parts of Radix Scrophulariaes, 10 parts of Cortex Moutans, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 30 parts of Herba Taraxacis, 10 parts of Herba Lophatheris, 30 parts of Rhizoma Imperataes, 15 parts of Radix Ophiopogonis, 12 parts of Cortex Phellodendris.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the Chinese medicine composition of the present invention: the Radix Rehmanniae has the effect of clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting, pain relieving regulating menstruation; Herba Cirsii has the effect of cooling blood for hemostasis, removing blood stasis to reduce swelling; Herba Agrimoniae has the effect of astringing to arrest bleeding, stomach invigorating preventing the attack (or recurrence) of malaria, detoxifcation treatment skin ulcer; Fructus Gardeniae has the effect of pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body; Herba Ecliptae has the effect of liver-nourishing kidney-boosting, cooling blood for hemostasis; Nodus Nelumbinis Rhizomatis has the effect of hemostasis dissipating blood stasis; The effect that the Rhizoma Anemarrhenae has clearing away heat-fire, promotes the production of body fluid and moisturize; Radix Scrophulariae has the effect of removing heat from blood YIN nourishing, eliminating fire and detoxication; Cortex Moutan has the effect of clearing away heat and cooling blood, promoting blood circulation to remove blood stasis; Radix Arnebiae (Radix Lithospermi) has the effect of clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, detoxifcation rash; Herba Taraxaci has the effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds; Herba Lophatheri has the effect of clearing heat and relieving fidgetness, diuresis; Rhizoma Imperatae has the effect of cooling blood for hemostasis, clearing away heat and promoting diuresis; Has the effect that YIN nourishing and the production of body fluid promoting, lung moistening clear away heart-fire Radix Ophiopogonis; Cortex Phellodendri has heat clearing and damp drying, pathogenic fire purging except the effect of steaming, skin ulcer is treated in detoxifcation.Drug component in the present composition is through dialectical compatibility, complements each other using, and has synergism, plays altogether the effect with heat clearing and damp drying, eliminating fire and detoxication, cooling blood for hemostasis, Yin-nourishing and body fluid promoting, blood circulation promoting and blood stasis dispelling, purpura reached the purpose for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the usefulness that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy, reliable effect, and the property of medicine is gentle, toxic and side effects do not occur, total effective rate 93.7%, cure rate reaches 71.4%.
The specific embodiment
The present invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of purpura, its raw material of Chinese medicine by following weight proportion forms: Radix Rehmanniae 30g, Herba Cirsii 30g, Herba Agrimoniae 30g, Fructus Gardeniae 12g, Herba Ecliptae 30g, Nodus Nelumbinis Rhizomatis 30g, Rhizoma Anemarrhenae 20g, Radix Scrophulariae 15g, Cortex Moutan 10g, Radix Arnebiae (Radix Lithospermi) 20g, Herba Taraxaci 30g, Herba Lophatheri 10g, Rhizoma Imperatae 30g, Radix Ophiopogonis 15g, Cortex Phellodendri 12g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of purpura, its raw material of Chinese medicine by following weight proportion forms: Radix Rehmanniae 40g, Herba Cirsii 15g, Herba Agrimoniae 10g, Fructus Gardeniae 20g, Herba Ecliptae 20g, Nodus Nelumbinis Rhizomatis 10g, Rhizoma Anemarrhenae 15g, Radix Scrophulariae 5g, Cortex Moutan 20g, Radix Arnebiae (Radix Lithospermi) 15g, Herba Taraxaci 40g, Herba Lophatheri 15g, Rhizoma Imperatae 20g, Radix Ophiopogonis 25g, Cortex Phellodendri 15g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of purpura, its raw material of Chinese medicine by following weight proportion forms: Radix Rehmanniae 10g, Herba Cirsii 20g, Herba Agrimoniae 25g, Fructus Gardeniae 15g, Herba Ecliptae 40g, Nodus Nelumbinis Rhizomatis 20g, Rhizoma Anemarrhenae 30g, Radix Scrophulariae 10g, Cortex Moutan 15g, Radix Arnebiae (Radix Lithospermi) 10g, Herba Taraxaci 20g, Herba Lophatheri 5g, Rhizoma Imperatae 40g, Radix Ophiopogonis 10g, Cortex Phellodendri 20g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of purpura, its raw material of Chinese medicine by following weight proportion forms: Radix Rehmanniae 20g, Herba Cirsii 40g, Herba Agrimoniae 20g, Fructus Gardeniae 5g, Herba Ecliptae 10g, Nodus Nelumbinis Rhizomatis 40g, Rhizoma Anemarrhenae 10g, Radix Scrophulariae 25g, Cortex Moutan 12g, Radix Arnebiae (Radix Lithospermi) 30g, Herba Taraxaci 10g, Herba Lophatheri 20g, Rhizoma Imperatae 25g, Radix Ophiopogonis 5g, Cortex Phellodendri 10g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of purpura, its raw material of Chinese medicine by following weight proportion forms: Radix Rehmanniae 15g, Herba Cirsii 10g, Herba Agrimoniae 40g, Fructus Gardeniae 10g, Herba Ecliptae 25g, Nodus Nelumbinis Rhizomatis 15g, Rhizoma Anemarrhenae 25g, Radix Scrophulariae 20g, Cortex Moutan 5g, Radix Arnebiae (Radix Lithospermi) 25g, Herba Taraxaci 15g, Herba Lophatheri 12g, Rhizoma Imperatae 10g, Radix Ophiopogonis 20g, Cortex Phellodendri 5g.
Chinese medicine composition in embodiment of the invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15~20 minutes, add water again and do not have about 8 centimetres of powder, carry out decocting the first time.Adopt intense fire to decoct at a simmer, it is rear with slow fire boiling 20~30 minutes to boil; Decoct for the second time, add water and do not have about 6 centimetres of powder, the water rear decoction 15~20 minutes of boiling.Twice decoction extracting juice that removes slag merges.
A kind of Chinese medicine composition for the treatment of purpura, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to observe case 63 examples, male 36 examples wherein, women 27 examples, 6~30 years old age.The course of disease 2~15 days.
Two, diagnosis basis:
(1), whole body or the visible point-like of extremity or speckle shape be hemorrhage, do not exceed skin, repeatedly outbreak.Or hemorrhage speckle slightly exceeds skin, and color is scarlet or dark red, and little itching can accompany the diseases such as stomachache or joint aches;
(2), can accompany low grade fever, bleeding from the gum, epistaxis, menorrhagia.Headache can appear in severe patient, and stupor is had blood in stool hematuria.
Three, usage and dosage: during clinical practice, the component in the compositions, consumption are taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.Seven days is a course for the treatment of, one day potion, the about 300ml of twice extracting juice of decocting, minute early, late twice half an hour ante cibum warm taking.Period in a medicine avoids eating anything raw or cold, pungent, stimulate and rotten thing, fry, fire burn and stodgy food should not be eaten more.
Four, efficacy evaluation:
(1) cure: the purple point of purpura and General Symptoms disappear, and it is normal that lab index is recovered;
(2) take a turn for the better: the cyanosis of the skin speckle obviously reduces, and General Symptoms alleviates, and lab index is improved;
(3) do not heal: cyanosis of the skin speckle, General Symptoms and lab index are all unchanged.
Five, therapeutic effect: in this clinical observation case, take medicine 1~4 course for the treatment of 45 examples of fully recovering, 14 examples that take a turn for the better, invalid 4 examples.Toxic and side effects does not occur during the treatment.
Six, model case:
Case 1:
The week certain, man, 8 years old.After the fever, many purpuras have appearred on the both legs skin, the extremities joint swelling pain, and umbilicus week and lower angina abdominis are diagnosed as anaphylactoid purpura.Take 1 course for the treatment of of medicament of Chinese medicine composition preparation of the present invention, arthroncus is disappeared, pain relief, and purpura is faded on the lower limb, continues to strengthen to take 2 courses for the treatment of, and all symptoms all disappear, and cure.
Case 2:
Guo, woman, 15 years old.The main suit: two lower limb purpuras suddenly occur without obvious inducement night, and buttocks to ankle sees that all companion's arthralgia is prone to stomachache during outbreak, and constipation with dry stool is graininess.Take 1 course for the treatment of of medicament of Chinese medicine composition preparation of the present invention, purpura before alleviates, and new blue point do not occur again, and it is still partially dried to defecate; Continue and take 1 course for the treatment of, the purple point of purpura and General Symptoms disappearance, healing.

Claims (2)

1. Chinese medicine composition for the treatment of purpura, it is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 10~40 parts in the Radix Rehmanniae, 10~40 parts of Herba Cirsiis, 10~40 parts of Herba Agrimoniaes, 5~20 parts of Fructus Gardeniae, 10~40 parts of Herba Ecliptaes, 10~40 parts of Nodus Nelumbinis Rhizomatis, 10~30 parts of the Rhizoma Anemarrhenaes, 5~25 parts of Radix Scrophulariaes, 5~20 parts of Cortex Moutans, 10~30 parts of Radix Arnebiae (Radix Lithospermi)s, 10~40 parts of Herba Taraxacis, 5~20 parts of Herba Lophatheris, 10~40 parts of Rhizoma Imperataes, 5~25 parts of Radix Ophiopogonis, 5~20 parts of Cortex Phellodendris.
2. a kind of Chinese medicine composition for the treatment of purpura according to claim 1, it is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 30 parts in the Radix Rehmanniae, 30 parts of Herba Cirsiis, 30 parts of Herba Agrimoniaes, 12 parts of Fructus Gardeniae, 30 parts of Herba Ecliptaes, 30 parts of Nodus Nelumbinis Rhizomatis, 20 parts of the Rhizoma Anemarrhenaes, 15 parts of Radix Scrophulariaes, 10 parts of Cortex Moutans, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 30 parts of Herba Taraxacis, 10 parts of Herba Lophatheris, 30 parts of Rhizoma Imperataes, 15 parts of Radix Ophiopogonis, 12 parts of Cortex Phellodendris.
CN201210347288.0A 2012-09-19 2012-09-19 Traditional Chinese medicine composition for treating purpura Expired - Fee Related CN102940793B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210347288.0A CN102940793B (en) 2012-09-19 2012-09-19 Traditional Chinese medicine composition for treating purpura

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210347288.0A CN102940793B (en) 2012-09-19 2012-09-19 Traditional Chinese medicine composition for treating purpura

Publications (2)

Publication Number Publication Date
CN102940793A true CN102940793A (en) 2013-02-27
CN102940793B CN102940793B (en) 2014-12-03

Family

ID=47723853

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210347288.0A Expired - Fee Related CN102940793B (en) 2012-09-19 2012-09-19 Traditional Chinese medicine composition for treating purpura

Country Status (1)

Country Link
CN (1) CN102940793B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103071028A (en) * 2013-03-01 2013-05-01 宋艳霞 Traditional Chinese medicinal composition for treating anaphylactoid purpura
CN104758728A (en) * 2015-04-23 2015-07-08 龚灿锋 Traditional Chinese medicine for treating purple patches in children

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101658643A (en) * 2009-09-15 2010-03-03 刘锋 Medicament for treating allergic purpura
CN102198222A (en) * 2011-05-31 2011-09-28 刘艳菊 Medicament for treating anaphylactoid purpura

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101658643A (en) * 2009-09-15 2010-03-03 刘锋 Medicament for treating allergic purpura
CN102198222A (en) * 2011-05-31 2011-09-28 刘艳菊 Medicament for treating anaphylactoid purpura

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李福玲等: "过敏性紫癜的中医药治疗概况", 《中医药信息》, vol. 23, no. 2, 31 March 2006 (2006-03-31), pages 18 - 20 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103071028A (en) * 2013-03-01 2013-05-01 宋艳霞 Traditional Chinese medicinal composition for treating anaphylactoid purpura
CN104758728A (en) * 2015-04-23 2015-07-08 龚灿锋 Traditional Chinese medicine for treating purple patches in children

Also Published As

Publication number Publication date
CN102940793B (en) 2014-12-03

Similar Documents

Publication Publication Date Title
CN102423402B (en) Traditional Chinese drug composition for treating night sweat
CN103463587A (en) Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach
CN105288371A (en) Traditional Chinese medicine composition for curing gout
CN103055116A (en) Traditional Chinese medicine composition for treating acnes
CN103611004A (en) Chinese medicine decoction for treating uremia
CN103169883B (en) Traditional Chinese medicine for treating infantile jaundice
CN102716334B (en) Chinese medicinal composition for dispelling the cold and removing stasis
CN102940793B (en) Traditional Chinese medicine composition for treating purpura
CN102940838B (en) Traditional Chinese medicine composition for treating constipation
CN103223139A (en) Traditional Chinese medicinal composition for treating chronic ulcerative colitis
CN103585596B (en) Traditional Chinese medicine composition for treating migraine
CN102949584B (en) Traditional Chinese medicine composition for treating purpura
CN104857463A (en) Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis
CN104998074A (en) Traditional Chinese medicine for treating gastropathy and preparation method thereof
CN103816493B (en) A kind of Chinese medicine composition treating instability of kidney QI
CN103800881A (en) Traditional Chinese medicine composition for treating heart-spleen deficiency syndrome
CN103705629B (en) A kind of Chinese medicine composition for the treatment of pruritus
CN102406913A (en) Chinese medicinal composition for treating melancholia
CN103735991A (en) Traditional Chinese medicine composition for treating purpura
CN105816603A (en) Traditional Chinese medicine composition for treating postpartum hemorrhage
CN104645002A (en) Traditional Chinese medicine composition for treating deficiency of liver-yin and kidney-yin
CN105250668A (en) Traditional Chinese medicine composition for treating purpura
CN102988805B (en) Traditional Chinese medicine composition for treating allergic purpura
CN103638174B (en) Traditional Chinese medicine for treating haemorrhoids
CN102688318B (en) Traditional Chinese medicine composition for treating segmental vitiligo

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: YU QING

Free format text: FORMER OWNER: RONGCHENG YATOU MEIQUAN DENTAL CLINIC

Effective date: 20141028

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Yu Qing

Inventor after: Liu Hui

Inventor before: Liu Hui

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LIU HUI TO: YU QING LIU HUI

Free format text: CORRECT: ADDRESS; FROM: 264300 WEIHAI, SHANDONG PROVINCE TO: 264500 WEIHAI, SHANDONG PROVINCE

TA01 Transfer of patent application right

Effective date of registration: 20141028

Address after: Rushan City Court Street in Weihai City, Shandong province 264500 No. 12

Applicant after: Yu Qing

Address before: 264300, No. 91, building No. 11, lotus pond North District, Weihai City, Shandong, Rongcheng

Applicant before: Rongcheng Yatou Meiquan Dental Clinic

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141203

Termination date: 20150919

EXPY Termination of patent right or utility model